PT-141 10mg peptide is a research-only vial of bremelanotide. Learn typical dosing, nasal spray differences, cost, and safety facts for researchers.
PT-141 10mg peptide is a single vial containing 10 milligrams of lyophilized bremelanotide, a synthetic melanocortin receptor agonist sold as a research chemical. The 10mg size is popular because it can be reconstituted into several different concentrations, which makes it flexible for laboratory work and dose-scaling studies. Research-grade PT-141 is not FDA-approved for human use, even though a prescription version of the same molecule does exist.
What PT-141 10mg Peptide Actually Is
Bremelanotide is a cyclic heptapeptide that binds melanocortin receptors, mainly MC4R, which are involved in pigmentation, appetite, and sexual function signaling. It was first studied as a self-tanning agent before researchers noticed effects on sexual desire.
PT-141 is supplied as a freeze-dried powder in sealed vials, usually in 5mg, 10mg, and 20mg sizes. A 10mg vial is the middle option and the most common one, because each vial can support multiple test concentrations without much waste.
- Form: white to off-white lyophilized powder
- Vial size: 10 mg of peptide per vial
- Storage: refrigerated or frozen and protected from light before reconstitution
- Reconstitution: typically with bacteriostatic water
How a 10mg Vial Is Reconstituted and Measured
The main reason researchers choose a 10mg vial is the math. Adding different volumes of bacteriostatic water to the same 10mg of powder changes the concentration, which changes how much liquid equals a given amount.
Here is how the numbers work out for a 10mg vial:
| Bacteriostatic water added | Concentration | Volume for 1 mg | Volume for 1.75 mg |
|---|---|---|---|
| 1 mL | 10 mg/mL | 0.10 mL (10 units) | 0.175 mL (17.5 units) |
| 2 mL | 5 mg/mL | 0.20 mL (20 units) | 0.35 mL (35 units) |
| 3 mL | 3.33 mg/mL | 0.30 mL (30 units) | 0.525 mL (about 53 units) |
100 units on a standard U-100 insulin syringe equals 1 mL. Published research often describes subcutaneous amounts in the 1.25 mg to 2 mg range, while older nasal studies used much larger amounts because nasal absorption is lower. Anyone reading a pt-141 peptide dosage chart should treat those figures as research references, not personal medical instructions.
PT-141 10mg vs. Nasal Spray vs. Prescription Pen
The same molecule is studied and sold in three very different formats, and they are not interchangeable. Absorption, onset time, and dose size change dramatically between them, which is why a pt-141 peptide nasal spray is not equivalent to a reconstituted 10mg vial.
| Format | Typical amount per dose | Onset | Notes |
|---|---|---|---|
| Reconstituted 10mg vial (subcutaneous) | About 1.25 to 2 mg in published research | 15 to 60 minutes | High absorption; requires sterile handling |
| Nasal spray | 7.5 to 20 mg in older studies | 30 to 60 minutes | Lower absorption, so larger amounts are needed |
| Vyleesi autoinjector (prescription) | 1.75 mg fixed dose | About 45 minutes | FDA-approved for premenopausal women with HSDD |
Because nasal delivery wastes more of the molecule, a 10mg vial used nasally would roughly equal one or two research doses. That same vial injected subcutaneously could support five to eight doses at 1.25 to 2mg.
Sourcing, Price, and Quality Checks
PT-141 is sold online by dozens of vendors, and typical pt-141 peptide price ranges from roughly $20 to $80 for a single 10mg vial depending on purity testing and shipping. Extremely cheap listings are usually a red flag.
- Third-party certificate of analysis (COA) with a batch number
- HPLC purity of 98% or higher
- Mass spectrometry confirmation of molecular weight
- Cold-chain or insulated shipping
- Clear labeling that the product is for research use only
People searching for pt-141 peptide near me are often looking for a clinic or compounding pharmacy, which is a different legal category from research chemical vendors. Independent lab testing matters far more than star ratings, because online reviews are easy to fabricate.
Reported Effects in Men and Women
Most clinical data comes from premenopausal women with hypoactive sexual desire disorder, where bremelanotide produced modest improvements in desire and reduced related distress. A pt-141 peptide for men is also widely discussed, but the published evidence in men is thinner and comes mainly from small erectile dysfunction studies using the nasal form.
Research in women has generally used lower amounts than the older nasal trials, which is one reason dosing conversations differ by population. Effects are usually reported within an hour and can last several hours, with an elimination half-life of about 2.7 hours.
Safety, Side Effects, and Legal Status
Common side effects reported in trials include nausea, flushing, headache, and injection-site reactions. A short-lived rise in blood pressure is one of the more serious concerns.
- Nausea, the most frequently reported effect
- Flushing and a sensation of warmth
- Headache
- Transient blood pressure increase
- Hyperpigmentation with frequent use
Bremelanotide is not recommended for people with uncontrolled high blood pressure or known cardiovascular disease. Anyone considering it should talk with a healthcare professional instead of self-dosing from a research vial.
PT-141 is a prescription drug in the United States, so selling it for human use without a prescription is not permitted. Research-grade PT-141 is not sterile, not standardized, and not intended for human consumption, so buyers should weigh those risks before ordering.
The Bottom Line
A PT-141 10mg peptide vial is a flexible research size that can be reconstituted to several concentrations, but it is not a finished pharmaceutical product. The FDA-approved version of bremelanotide is a 1.75mg autoinjector approved for a specific diagnosis in premenopausal women. Anyone comparing options should prioritize verified purity, understand the legal limits, and consult a licensed clinician before putting any peptide into the body.
Frequently Asked Questions
Is PT-141 10mg the same as the prescription version?
No. A 10mg PT-141 vial is a bulk research chemical holding 10 milligrams of lyophilized bremelanotide powder, while the FDA-approved prescription product (Vyleesi) is a single-use autoinjector that delivers a fixed 1.75mg dose. The research vial requires reconstitution and sterile handling and is not manufactured to pharmaceutical standards.
How long does PT-141 take to work and how long does it last?
In published studies, effects typically begin within 15 to 60 minutes after subcutaneous use and can last several hours. The elimination half-life of bremelanotide is roughly 2.7 hours. Nasal forms tend to have a slower and more variable onset than injected forms.
Can you legally buy PT-141 in the United States?
PT-141 is a prescription drug in the US, so it cannot legally be sold for human use without a prescription. Products marketed as research use only sit in a regulatory gray area and are often not tested for sterility or accurate dosing. Buyers should understand those risks and consult a licensed healthcare professional.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.